Suppr超能文献

相似文献

2
Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients.
Mol Genet Metab. 2004 Apr;81 Suppl 1:S79-85. doi: 10.1016/j.ymgme.2003.11.017.
3
In vivo nitrogen metabolism in ornithine transcarbamylase deficiency.
J Clin Invest. 1996 Nov 1;98(9):2167-73. doi: 10.1172/JCI119023.
4
Acute effects of phenylbutyrate on glutamine, branched-chain amino acid and protein metabolism in skeletal muscles of rats.
Int J Exp Pathol. 2017 Jun;98(3):127-133. doi: 10.1111/iep.12231. Epub 2017 Jun 16.
5
6
Restoration of nitrogen homeostasis in a man with ornithine transcarbamylase deficiency.
Metabolism. 1993 Oct;42(10):1336-9. doi: 10.1016/0026-0495(93)90135-b.
7
8
Sodium phenylbutyrate decreases plasma branched-chain amino acids in patients with urea cycle disorders.
Mol Genet Metab. 2014 Sep-Oct;113(1-2):131-5. doi: 10.1016/j.ymgme.2014.06.005. Epub 2014 Jul 3.

引用本文的文献

1
Monitoring the treatment of urea cycle disorders using phenylbutyrate metabolite analyses: Still many lessons to learn.
Mol Genet Metab. 2023 Nov;140(3):107699. doi: 10.1016/j.ymgme.2023.107699. Epub 2023 Sep 11.
2
Humanized liver mouse model with transplanted human hepatocytes from patients with ornithine transcarbamylase deficiency.
J Inherit Metab Dis. 2021 May;44(3):618-628. doi: 10.1002/jimd.12347. Epub 2020 Dec 30.
3
Ex Vivo Enteroids Recapitulate In Vivo Citrulline Production in Mice.
J Nutr. 2018 Sep 1;148(9):1415-1420. doi: 10.1093/jn/nxy126.
4
Single amino acid supplementation in aminoacidopathies: a systematic review.
Orphanet J Rare Dis. 2014 Jan 13;9:7. doi: 10.1186/1750-1172-9-7.
5
Treatment of Niemann--pick type C disease by histone deacetylase inhibitors.
Neurotherapeutics. 2013 Oct;10(4):688-97. doi: 10.1007/s13311-013-0217-2.

本文引用的文献

1
Phenylbutyrate therapy for maple syrup urine disease.
Hum Mol Genet. 2011 Feb 15;20(4):631-40. doi: 10.1093/hmg/ddq507. Epub 2010 Nov 23.
2
Cross-sectional multicenter study of patients with urea cycle disorders in the United States.
Mol Genet Metab. 2008 Aug;94(4):397-402. doi: 10.1016/j.ymgme.2008.05.004. Epub 2008 Jun 17.
3
Manipulation of citrulline availability in humans.
Am J Physiol Gastrointest Liver Physiol. 2007 Nov;293(5):G1061-7. doi: 10.1152/ajpgi.00289.2007. Epub 2007 Sep 27.
4
Leucine and protein synthesis: mTOR and beyond.
Nutr Rev. 2007 Mar;65(3):122-9. doi: 10.1111/j.1753-4887.2007.tb00289.x.
5
Acute depletion of plasma glutamine increases leucine oxidation in prednisone-treated humans.
Clin Nutr. 2007 Apr;26(2):231-8. doi: 10.1016/j.clnu.2006.09.010. Epub 2006 Nov 13.
6
Arginase induction by sodium phenylbutyrate in mouse tissues and human cell lines.
Mol Genet Metab. 2007 Jan;90(1):37-41. doi: 10.1016/j.ymgme.2006.07.002. Epub 2006 Aug 28.
7
Considerations in the difficult-to-manage urea cycle disorder patient.
Crit Care Clin. 2005 Oct;21(4 Suppl):S19-25. doi: 10.1016/j.ccc.2005.05.001.
8
Observations of branched-chain amino acid administration in humans.
J Nutr. 2005 Jun;135(6 Suppl):1580S-4S. doi: 10.1093/jn/135.6.1580S.
9
The role of leucine in the regulation of protein metabolism.
J Nutr. 2005 Jun;135(6 Suppl):1553S-6S. doi: 10.1093/jn/135.6.1553S.
10
Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients.
Mol Genet Metab. 2004 Apr;81 Suppl 1:S79-85. doi: 10.1016/j.ymgme.2003.11.017.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验